Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: A systematic review

Addiction

Volumn 99, Issue 7, 2004, Pages 811-828

  Carmen, Bouza ^a,b   Angeles, Magro ^a   Ana, Muñoz ^a   María, Amate José ^a  

^a The Spanish Network of Agencies for Health Technology Assessment and Services of the National Health System   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Acamprosate; Alcohol dependence; Alcoholism treatment; Meta analysis; Naltrexone

Indexed keywords

ACAMPROSATE; ALCOHOL; NALTREXONE;

ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOLISM; ASTHENIA; CALCULATION; CLINICAL TRIAL; DATA ANALYSIS; DIARRHEA; DIZZINESS; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; DRUG SAFETY; DRUG SCREENING; DRUG TOLERABILITY; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; LIVER DYSFUNCTION; MENTAL DISEASE; META ANALYSIS; METHODOLOGY; MODEL; NAUSEA; OUTCOMES RESEARCH; PATIENT; PATIENT COMPLIANCE; PRURITUS; PSYCHOSOCIAL CARE; QUALITATIVE ANALYSIS; RECURRENCE RISK; RELAPSE; REVIEW; SIDE EFFECT; SYSTEMATIC REVIEW;

ALCOHOL DETERRENTS; ALCOHOLISM; HUMANS; NALTREXONE; NARCOTIC ANTAGONISTS; RANDOMIZED CONTROLLED TRIALS; TAURINE; TREATMENT OUTCOME;

EID: 3042823950     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2004.00763.x     Document Type: Review

References (75)

1. Chick, J. & Erickson, C. K. (1996) Conference summary: consensus conference on alcohol dependence and the role of pharmacotherapy in its treatment. Alcoholism: Clinical and Experimental Research, 20, 391-402.
2. Fuchs, C. S., Stampfer, M. J., Colditz, G. A., Giovannucci, E. L., Manson, J. E., Kawachi, I., Hunter, D. J., Hankinson, S. E., Hennekens, C. H. & Rosner, B. (1995) Alcohol consumption and mortality among women. New England Journal of Medicine, 332, 1245-1250.
3. Ashworth, M. & Gerada, C. (1997) ABC of mental health: addiction and dependence-II: Alcohol. BMJ, 315, 358-360.
4. Swift, R. M. (1999) Drug therapy for alcohol dependence. New England Journal of Medicine, 340, 1482-1490.
5. O'Malley, S. S. (1998) Naltrexone and alcoholism treatment. Treatment Improvement Protocol (TIP) Series 28. NCADI, 15-10-1998. Rockville, MD: US Department of Health and Human Services. http://www.health.org/govpubs/BKD268. Accessed 21 December 2002.
6. Boening, J., Lesch, O. M., Spanagel, R., Wolffgramm, J., Narita, M., Sinclair, D., Mason, B. & Wiesbeck, G. A. (2001) Pharmacological relapse prevention in alcohol dependence: from animal models to clinical trials. Alcoholism; Clinical and Experimental Research, 25, 127-131.
7. Sinclair, J. D. (1990) Drugs to decrease alcohol drinking. Annals of Medicine. 22, 357-362.
8. Holder, H. D., Cisler, R. A., Longabaugh, R., Stout, R. L., Treno, A. J. & Zweben, A. (2000) Alcoholism treatment and medical care costs from Project MATCH. Addiction, 95, 999-1013.
9. O'Malley, S. S., Jaffe, A. J., Chang, G., Schottenfeld, R. S., Meyer, R. E. & Rousanville, B. (1992) Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Archives of General Psychiatry, 49, 881-887.
10. Volpicelli, J. R., Alterman, A. I., Hayashida, M. & O'Brien, C. P. (1992) Naltrexone in the treatment of alcohol dependence. Archives of General Psychiatry, 49, 876-880.
11. Sinclair, J. D, (2001) Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism. Alcohol and Alcoholism, 36, 2-10.
12. Hunt, W. A. (1993) Neuroscience research: how has it contributed to our understanding of alcohol abuse and alcoholism? A review. Alcoholism: Clinical and Experimental Research, 17, 1055-1065.
13. Littleton, J. M. (1995) Acamprosate in alcohol dependence; how does it work? Addiction, 90, 1179-1188.
14. Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J., Gavaghan, D. J. & McQuay, H. J. (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clinical Trials, 17, 1-12.
15. Hadorn, D. C., Baker, D., Hodges, J. S. & Hicks, N. (1996) Rating the quality of evidence for clinical practice guidelines. Journal of Clinical Epidemiology, 49, 749-754.
16. Tang, J. & Liu, J. L. (2000) Misleading funnel plot for detection of bias in meta-analysis. Journal of Clinical Epidemiology, 53, 477-484.
17. Modesto-Lowe, V., Burleson, J. A., Hersh, D., Bauer, L. O. & Kranzler, H. R. (1997) Effects of naltrexone on cue-elicited craving for alcohol and cocaine. Drug and Alcohol Dependence, 49, 9-16.
18. Jaffe, A. J. & Rounsaville, B. (1996) Naltrexone, relapse prevention, and supportive therapy with alcoholics. An analysis of patient treatment matching. Journal of Consulting and Clinical Psychology, 64, 1044-1053.
19. Pettinati, H. M., Volpicelli, J. R., Pierce, J. D. & O'Brien, C. P. (2000) Improving naltrexone response: an intervention for medical practitioners to enhance medication compliance in alcohol dependent patients. Journal of Addictive Diseases, 19, 71-83.
20. Besson, J., Aeby, F., Kasas, A., Lehert, P. & Potgieter, A. (1998) Combined efficacy of acamprosate and disulfiram in the treatment of alcoholism: a controlled study. Alcoholism: Clinical and Experimental Research, 22, 573-579.
21. Chick, J., Howlett, H., Morgan, M. Y. & Ritson, B. (2000) United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol. Alcohol and Alcoholism, 35, 176-187.
22. Geerlings, P. J., Ansoms, C. & Van den Brink, W. (1997) Acamprosate and prevention of relapse in alcoholics. Results of a randomized, placebo-controlled, double-blind study in out-patient alcoholics in the Netherlands, Belgium and Luxembourg. European Addiction Research, 3, 129-137.
23. Gual, A. & Lehert, P. (2001) Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain. Alcohol and Alcoholism, 36, 413-418.
24. Ladewig, D., Knecht, T. & Lehert, P. (1993) Acamprosate - a stabilizing factor in long-term withdrawal of alcoholic patients. Therapeutische Umschau, 50, 182-188.
25. Lhuintre, J. P., Moore, N., Tran, G., Steru, L., Langrenon, S., Daoust, M., Parot, P., Ladure, P., Libert, C. & Boismare, F. (1990) Acamprosate appears to decrease alcohol intake in weaned alcoholics. Alcohol and Alcoholism, 25, 613-622.
26. Paille, F. M., Guelfi, J. D., Perkins. A. C., Royer, R. J., Steru, L. & Parot, P. (1995) Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol. Alcohol and Alcoholism, 30, 239-247.
27. Pelc, I., Verbanck, P., Le Bon, O., Gavrilovic, M., Lion, K. & Lehert, P. (1997) Efficacy and safety of acamprosate in the treatment of detoxified alcohol-dependent patients. A 90-day placebo-controlled dose-finding study. British Journal of Psychiatry, 171, 73-77.
28. Poldrugo, F. (1997) Acamprosate treatment in a long-term community-based alcohol rehabilitation programme, Addiction, 92, 1537-1546.
29. Roussaux, J. P. & Hersh, D. (1996) Does acamprosate diminish the appetite for alcohol in weaned alcoholics? Journal de Pharmacie de Belgique, 51, 65-68.
30. Sass, H., Soyka, M., Mann, K. & Zieglgansberger, W. (1996) Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence. Archives of General Psychiatry, 53, 673-680.
31. Tempesta, E., Janiri, L., Bignamini, A., Chabac, S. & Potgieter, A. (2000) Acamprosate and relapse prevention in the treatment of alcohol dependence: a placebo-controlled study. Alcohol and Alcoholism, 35, 202-209.
32. Whitworth, A. B., Fischer, F., Lesch, O. M., Nimmerrichter, A., Oberbauer, H., Platz, T., Potgieter, A., Walter. H. & Fleischhacker, W. W. (1996) Comparison of acamprosate and placebo in long-term treatment of alcohol dependence. Lancet, 347, 1438-1442.
33. Anton, R. F., Moak, D. H., Waid, L. R., Latham, P. K., Malcolm, R. J. & Dias, J. K. (1999) Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial. American Journal of Psychiatry, 156, 1758-1764.
34. Anton, R. F., Moak, D. H., Latham, P. K., Waid, R., Malcolm, R. J., Dias, J. K. & Roberts, J. S. (2001) Posttreatment results of combining naltrexone with cognitive-behavior therapy for the treatment of alcoholism. Journal of Clinical Psychopharmacology, 21, 72-77.
35. Chick, J., Anton, R., Checinski, K., Croop, R., Drummond, D. C., Farmer, R., Labriola, D., Marshall, J., Moncrieff, J., Morgan, M. Y., Peters, T. & Ritson, B. (2000) A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse. Alcohol and Alcoholism, 35, 587-593.
36. Croop, R. S., Faulkner, E. B. & Labriola, D. F. (1997) The safety profile of naltrexone in the treatment of alcoholism. Results from a multi-centre usage study. The Naltrexone Usage Study Group. Archives of General Psychiatry, 54, 1130-1135.
37. Guardia, J., Caso, C., Arias, F., Gual, A., Sanahuja, J., Ramirez, M., Mengual, I., Gonzalvo, B., Segura, L., Trujols, J. & Casas, M. (2002) A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multi-centre clinical trial. Alcoholism: Clinical and Experimental Research, 26, 1381-1387.
38. Heinala, P., Alho, H., Kiianmaa, K., Lunnqvist, J., Kuoppasalmi, K. & Sinclair, J. D. (2001) Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial. Journal of Clinical Psychopharmacology, 21, 287-292.
39. Hersh, D., Van Kirk, J. R. & Kranzler, H. R. (1998) Naltrexone treatment of comorbid alcohol and cocaine use disorders. Psychopharmacology, 139, 44-52.
40. Knox, P. C. & Donovan, D. M. (1999) Using naltrexone in inpatient alcoholism treatment. Journal of Psychoactive Drugs, 31, 373-388.
41. Kranzler, H. R., Modesto-Lowe, V. & Van Kirk, J. (2000) Naltrexone versus nefazodone for treatment of alcohol dependence. A placebo-controlled trial. Neuropsychopharmacology, 22, 493-503.
42. Krystal, J. H., Cramer, J. A., Krol, W. F., Kirk, G. F. & Rosenheck, R. A. for the Veterans Affairs Naltrexone Cooperative Study 425 Group (2001) Naltrexone in the treatment of alcohol dependence. New England Journal of Medicine, 345, 1734-1739.
43. Landabaso, M. A., Iraurgi, I., Sanz, J., Calle, R., Ruiz de Apodaka, J., Jimenez-Lerma, J. M. & Gutierrez-Fraile, M. (1999) Naltrexone in the treatment of alcoholism: two-year follow up results. European Journal of Psychiatry, 13, 97-105.
44. Latt, N. C., Jurd, S., Houseman, J. & Wutzke, S. E. (2002) Naltrexone in alcohol dependence: a randomised controlled trial of effectiveness in a standard clinical setting. Medical Journal of Australia, 176, 530-534.
45. Monti, P. M., Rohsenow, D. J., Swift, R. M., Gulliver, S. B., Colby, S. M., Mueller, T. I., Brown, R. A., Gordon, A., Abrams, D. B., Niaura, R. S. & Asher, M. K. (2001) Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1-year outcomes. Alcoholism: Clinical and Experimental Research, 25, 1634-1647.
46. Morris, P. L., Hopwood, M., Whelan, G., Gardiner, J. & Drummond, E. (2001) Naltrexone for alcohol dependence: a randomized controlled trial. Addiction, 96, 1565-1573.
47. O'Malley, S. S., Jaffe, A. J., Chang, G., Rode, S., Schottenfeld, R., Meyer, R. E. & Rousanville, B. (1996) Six-month follow-up of naltrexone and psychotherapy for alcohol dependence. Archives of General Psychiatry, 53, 217-224.
48. Oslin, D., Liberto, J. G., O'Brien, J., Krois, S. & Norbeck, J. (1997) Naltrexone as an adjunctive treatment for older patients with alcohol dependence. American Journal of Geriatric Psychiatry, 5, 324-332.
49. Rubio, G., Jimenez-Arriero, M. A., Ponce, G. & Palomo, T. (2001) Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment. Alcohol and Alcoholism, 36, 419-425.
50. Volpicelli, J. R., Clay, K. L., Watson, N. T. & O'Brien, C. P. (1995) Naltrexone in the treatment of alcoholism; predicting response to naltrexone. Journal of Clinical Psychiatry, 56, 39-44.
51. Volpicelli, J. R., Rhines, K. C., Rhines, J. S., Volpicelli, L. A., Alterman, A. I. & O'Brien, C. P. (1997) Naltrexone and alcohol dependence. Role of subject compliance. Archives of General Psychiatry, 54, 737-742.
52. Wilde, M. & Wagstaff, A. (1997) Acamprosate, a review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification. Drugs, 56, 1038-1053.
53. Hoes, M. (1999) Relapse prevention in alcoholics: a review of acamprosate versus naltrexone. Clinical Drug Investigation. 17, 211-216.
54. Kranzler, H. R. & Van Kirk, J. (2001) Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis. Alcoholism: Clinical and Experimental Research, 25, 1335-1341.
55. Berglund, M., Andreasson, S. & Franck. J. (2002) Treatment of alcohol and drug abuse - an evidence-based review. http://www.sbu.se/admin/Docs/PUB/ 833/drugslut.htm. Accessed 21 January 2003.
56. Agosti, V. (1995) The efficacy of treatments in reducing alcohol consumption: a meta-analysis. International Journal of the Addictions, 30, 1067-1077.
57. Srisurapanont, M. & Jarusuraisin, N. (2002) Opioid antagonists for alcohol dependence (Cochrane Review). Cochrane Library, issue 1.
58. Streeton, C. & Whelan, G. (2001) Naltrexone, a relapse prevention maintenance treatment of alcohol dependence: a meta-analysis of randomized controlled trials. Alcohol and Alcoholism, 36, 544-552.
59. West, S. L., Garbutt, J. C. & Carey, T. S. (1999) Pharmacotherapy for alcohol dependence. Summary, evidence report/technology assessment. Agency for Health Care Policy and Research. 3. AHCPR Publication No. 99-E004. http://www.ahcpr.gov
60. Agosti, V. (1994) The efficacy of controlled trials of alcohol misuse treatments in maintaining abstinence: a meta-analysis. International Journal of the Addictions, 29, 759-769.
61. Fleiss, J. (1994) Measures of Effect Size for Categorical Data. In: Cooper, H. & Hedges, L. V., eds. The Handbook of Research Synthesis. New York: Russell Sage Foundation.
62. Hopayian, K. (2001) The need for caution in interpreting high quality systematic reviews. BMJ, 323, 681-684.
63. De Wildt, W. A. J. M., Schippers, G. M., Van den Brink, W. Potgieter, A. S., Deckers, F. & Bets, D. (2002) Does psychosocial treatment enhance the efficacy of acamprosate in patients with alcohol problems? Alcohol and Alcoholism, 37, 375-382.
64. Oncken, C., Van Kirk, J. & Kranzler, H. R. (2001) Adverse effects of oral naltrexone: analysis of data from two clinical trials. Psychopharmacology, 154, 397-402.
65. Hughes, D. A., Bagust, A., Haycox, A. & Walley, T. (2001) The impact of non-compliance on the cost-effectiveness of pharmaceuticals. A review of the literature. Health Economics, 10, 601-615.
66. Allen, J. P., Litten, R. Z., Strid, N. & Sillanaukee, P. (2001) The role of biomarkers in alcoholism medication trials. Alcoholism: Clinical and Experimental Research, 25, 1119-1125.
67. Egger, M. & Davey Smith, G. (1998) Bias in location and selection of studies. BMJ, 316, 61-66.
68. Cook, D. J., Guyatt, G. H., Ryan, G., Clifton, J., Buckingham, L., Willan, A., McIlroy, W. & Oxman, A. D. (1993) Should unpublished data be included in meta-analysis? Current convictions and controversies. Journal of the American Medical Association, 269, 2749-2753.
69. Song, F., Eastwood, A. J., Gibody, S., Duley, L. & Sutton, A. J. (2000) Publication and related biases. Health Technology Assessment, 4, 1-105.
70. Egger, M., Juni, P., Bartlett, C., Holestein, F. & Sterne, J. (2003) How important are comprehensive literature searches and the assessment of trial quality in systematic reviews. Empirical study. Health Technology Assessment, 7, 1-75.
71. Davey Smith, G. & Egger, M. (1998) Meta-analysis: unresolved issues and future developments. BMJ, 316, 221-225.
72. Ferguson, D., Laupacis, A., Salmi, L. R., McAlister, F. A. & Huet, C. (2000) What should be included in meta-analysis? An exploration of methodological issues. International Journal of Technology Assessment in Health Care, 16, 1109-1119.
73. Jadad, A. R., Moher, D. & Klassen, T. P. (1999) Guides for reading and interpreting systematic reviews. II. How did the authors find the studies and assess their quality. Archives of Pediatrics and Adolescent Medicine, 152, 812-817.
74. Oxman, A. D. & Guyatt, G. H. (1991) Validation of an index of the quality of review articles. Journal of Clinical Epidemiology, 44, 1271-1278.
75. Greenland, S. (1994) Invited commentary: a critical look at some popular meta-analytic methods. American Journal of Epidemiology, 140, 290-296.